Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Business pharma | History Defined

Estrogen Shortage Spreads From Patches to Injections and Vaginal Creams as Women Face Refill Gaps and Coverage Hurdles

Estradiol injection products and vaginal creams are facing shortages or allocation as patients shift from hard-to-find patches, creating refill, insurance and treatment challenges.

Medical Daily · 5h ago

Biotech Groups File Second Lawsuit Against Medicare's GLOBE Pilot, Opening a California Front Before January Launch

Three biotechnology trade groups sued Medicare over the GLOBE pricing model, adding a second legal challenge before the program could lower costs for some Part B patients in 2027.

Medical Daily · 16h ago

Pentagon Removes Drug Contractor WuXi AppTec From Chinese Military List After Court Ruling, Leaving Relisting Possible

The Pentagon removed WuXi AppTec from its Chinese military companies list after a court order, but the lawsuit continues and the company could face relisting or separate restrictions.

Medical Daily · 16h ago

From analysis to the latest developments in health,
read the most diverse news in one place.

Company That Never Worked on Ebola Won $18.8 Million CDC Contract to Screen Travelers at U.S. Airports

XpresTest, a subsidiary of XWELL, received an $18.8 million CDC contract for Ebola screening at U.S. airports despite having no previous Ebola experience, prompting scrutiny.

Medical Daily · Nov 11

Federal Preventive Task Force Ethics Waivers Cover Every Member, Including Two Who Own Private Medical Practices

Federal officials granted ethics waivers to all 16 members of the U.S. Preventive Services Task Force, raising questions about conflicts involving medical practices, stocks and academic employers.

Medical Daily · Nov 11

3 Insider Selling Stories; 3 Different Signals for Investors

Insiders at Liquidia, Brinker International and Procter & Gamble have been selling shares, but context like analyst targets, institutional ownership and earnings trends shows the signals differ by company.

MarketBeat · Nov 11

Sali Hughes on beauty: a lotion to cure autumn dryness – and relieve eczema sufferers’ sore skin

Bioderma’s new eczema lotion will be comforting for anyone with dry skin. Plus another brilliant problem solving mosituriser

The Guardian - UK · Nov 11

Read news from The Economist, FT, and more,
with one subscription

PhRMA Spent an Estimated $58.8 Million on Search Ads, With Nearly Half Steering Users to Anti-PBM Pages

An analysis estimates that PhRMA spent $58.8 million on paid search ads from 2019 to 2025, with nearly half directing users to pages criticizing pharmacy benefit managers.

Medical Daily · Nov 10

The FDA Ordered GLP-1 Vision-Loss Warnings For Some Products. Shares of Eli Lilly and Novo Nordisk Were Unfazed.

The updated labeling covers Mounjaro, Zepbound, Ozempic and Wegovy.

International Business Times · Nov 10

Eugia Recalls One Lot of Vancomycin Injection Nationwide After a Glass Particle Was Found Inside a Vial

Eugia is recalling lot 3VM26026A of injectable vancomycin after a glass particle was found in a vial, warning of potentially serious risks including blood clots and organ damage.

Medical Daily · Nov 10

Scotland’s first drug-checking service begins operations

Minister Maree Todd said the facility will save lives and help tackle the country’s high drug death rate.

Evening Standard · Nov 9

New 'life-saving' drug-testing facility opens in Glasgow

Scotland's first drug-checking service has officially opened in Glasgow

The National (Scotland) · Nov 9

Four of Kennedy's Eight New Preventive Task Force Members Kept Drug Company Stocks Under Federal Ethics Waivers

Four members appointed by Robert F. Kennedy Jr. to the U.S. Preventive Services Task Force received waivers allowing them to retain health company stocks while serving.

Medical Daily · Nov 8

Hims Agrees to Stop Selling Compounded Lilly Obesity Drugs as Zepbound and Foundayo Join Platform

Hims will sell Lilly's Zepbound and Foundayo directly while ending compounded copies of the company's obesity drugs on its platform. Patients buying elsewhere still face quality and dosing risks.

Medical Daily · Nov 8

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily · Nov 7

Novartis Confirms Nine Tumor Reports After Zolgensma Gene Therapy, With Two Showing Signs of Vector DNA Integration

Little Giant is recalling about 3.66 million ladders after 19 injury reports, including head injuries, from sudden retractions. How to check yours.

Medical Daily · Nov 6

Seizure Drug Cenobamate Seeks FDA Nod for Generalized Seizures and Children After 71.9% Median Reduction in Trial

SK Biopharmaceuticals has asked the FDA to expand cenobamate's use to generalized seizures in patients 12 and older and focal seizures in children after positive Phase 3 results.

Medical Daily · Nov 6

Second Generic Venetoclax Wins Final FDA Approval for Leukemia, but Launch Date and Price Remain Unannounced

The FDA approved Alembic Pharmaceuticals' generic venetoclax tablets for certain leukemia patients, but the drug's launch date, price and potential savings remain unknown.

Medical Daily · Nov 5

Medicare Cuts 340B Drug Payments and Off-Campus Imaging Rates in 2027, Which CMS Says Will Lower Copays

A new CMS rule will reduce Medicare payments for 340B drugs and certain imaging services in 2027, lowering some patient costs while prompting hospitals to warn of service cuts.

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily · Nov 5

CVS Health Will Split Aetna and Caremark From Its 9,000 Pharmacies, Creating Two Public Companies by Mid-2028

CVS Health plans to separate its retail pharmacy operations from Aetna, Caremark and related health services by the first half of 2028, pending regulatory and board approvals.

Medical Daily · Nov 5

Lupin's Generic Firdapse Approved for Rare Lambert-Eaton Syndrome, but a Patent Deal Delays U.S. Sales to 2035

The FDA approved Lupin's generic Firdapse, but a patent settlement bars U.S. sales until February 2035, limiting near-term savings for patients who need treatment for rare LEMS.

The Guardian - US · Nov 4

CVS Health to split pharmacy chain from health insurance

CVS Pharmacy will be separate from CVS Health, housing major insurer Aetna and benefits manager Caremark

Medical Daily · Nov 4

Botox Must Be Excluded From Medicare Price Negotiation, Judge Rules, Citing Ingredient Made From Human Blood Plasma

A federal judge ruled that Botox qualifies for Medicare's plasma-derived drug exemption, blocking a negotiated price that would have taken effect in 2028 unless the decision is overturned.

Medical Daily · Nov 4

Medicare Prices for Botox, Biktarvy, and 13 Other Drugs Must Be Public by November 30 After Talks End

Medicare finished negotiating prices for 15 drugs, including Botox and Trulicity. CMS must publish agreed prices by November 30, with the new prices taking effect in 2028.

The Guardian - UK · Nov 4

Why pharma firms are going to Earth’s orbit in search of new cancer drugs

A space capsule 300 miles above us is growing the tiny crystals of a potential cancer drug in microgravity

The Economic Times · Nov 4

Emcure Pharma shares hit 10% upper circuit after FY27 guidance hike; Jefferies raises target price by 8%

Emcure Pharma shares hit a 10% upper circuit after strong Q2 FY27 results prompted the company to raise its full-year growth guidance. Brokerages turned more positive, citing robust international business, improving domestic growth and a strong product pipeline.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.